Conavi Medical (TSE:CNVI) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Conavi Medical’s Novasight Hybrid System, which uniquely combines IVUS and OCT for comprehensive coronary artery imaging, has been highlighted in a peer-reviewed article for its potential to improve cardiovascular procedures. This innovative technology is currently being showcased at the TCT 2024 conference, emphasizing its promising future in enhancing patient care.
For further insights into TSE:CNVI stock, check out TipRanks’ Stock Analysis page.
